home All News open_in_new Full Article
Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
today 12 h. ago attach_file Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
ID: 2861530063